Synthesis and Characterization of Centhaquin and its Citrate Salt and a Comparative Evaluation of their Cardiovascular Actions

Abstract

Centhaquin is a compound that produces hypotension and bradycardia in higher doses and resuscitation in lower doses. It is water insoluble, and is unsuitable for intravenous use. We prepared the citrate salt of centhaquin and evaluated its cardiovascular efficacy vs. centhaquin. Centhaquin citrate was prepared and characterized; its purity was determined by HPLC. Mean arterial pressure (MAP), heart rate (HR), pulse pressure (PP), cardiac output (CO), stroke volume (SV) and stroke work (SW) following intravenous administration of centhaquin and the citrate (0.05, 0.15 and 0.45 mg.kg⁻¹) were determined in anaesthetized male Sprague-Dawley rats. Centhaquin citrate was 99.8% pure and water soluble. Centhaquin (0.05, 0.15 and 0.45 mg.kg⁻¹) produced a maximal decrease in MAP of 15.6, 25.2 and 28.1%, respectively; while centhaquin citrate produced a greater (p<0.001) decrease of 35.7, 47.1 and 54.3%, respectively. The decrease in PP and HR produced by the citrate was greater than centhaquin (p<0.001). At 0.45 mg.kg⁻¹ centhaquin produced a maximal decrease of 20.9% (p<0.01) in CO, while centhaquin citrate produced a decrease of 42.1% (p<0.001). Reduction in SV (p<0.01) and SW (p<0.001) produced by centhaquin citrate were greater than centhaquin. Centhaquin citrate has greater cardiovascular activity compared to centhaquin.

Key words

mean arterial pressure - HPLC - blood pressure - heart rate - cardiac output

• References

• 1 Murthi VA, Jain PC, Sharma JN et al. 1-Substituted 4-(β-2-quinolylethyl)piperazines and 1,2,3,4-tetrahydroquinolyl-ethyl analogues thereof. United States Patent US 3,983,121 (1976)
• 2 Murti A, Bhandari K, Ram S et al. Synthesis and QSAR of 1-aryl-4-(β-2-quinolyl/1-isoquinolylethyl)piperazines and some related compounds as hypotensive agents. Indian J Chem 1989; 28B: 934-942
• 3 Carpy A, Saxena AK. Structure of 1-(3-methylphenyl)-4-(2-beta-quinolylethyl)piperazine: centhaquin. Acta Crystallogr 1991; C47: 227-229
• 4 Bajpai UC, Gupta DC, Singh RB et al. Fourier transform infrared spectra and normal mode analysis of 1-(3-methylphenyl piperazin-1-yl)-2-(quinolin-2-yl)ethane (Centhaquin): a potent centrally acting anti-hypertensive agent. J Mol Struct 2000; 516: 15-21
• 5 Bhatnagar M, Pande M, Dubey MP et al. Effect of Centhaquine on Spontaneous and Evoked Norepinephrine Release from Isolated Perfused Rabbit Heart. Arzneim Forsch 1985; 35: 693-697
• 6 Srimal RC, Mason DFJ, Dhawan BN. Studies on 2-(2-(4-(3-methyl­phenyl)1-piperazinyl)ethyl quinoline (centhaquine), a centrally acting antihypertensive II. Effect of cardiohemodynamics. Asia Pac J Pharmacol 1990; 5: 185-190
• 7 Srimal RC, Gulati K, Nityanand S et al. Pharmacological studies on 2-(2-(4-(3-met­hylphenyl)-1-piperazinyl)ethyl) quinoline (centhaquin). I. Hypotensive activity. Pharmacol Res 1990; 22: 319-329
• 8 Gulati A, Hussain G, Srimal RC. Effect of repeated administration of centhaquin, a centrally acting hypotensive drug, on adrenergic, cholinergic (muscarinic), dopaminergic, and serotonergic receptors in brain-regions of rat. Drug Dev Res 1991; 23: 307-323
• 9 Gaur SPS, Puri VN, Asthana OP. Effect of centhaquin on renal functions of normal human subjects. Indian J Chem 1995; 27: 56
• 10 Gulati A, Lavhale MS, Garcia DJ et al. Centhaquin improves resuscitative effect of hypertonic saline in hemorrhaged rats. J Surg Res 2012; 178: 415-423
• 11 Lavhale MS, Havalad S, Gulati A. Resuscitative effect of centhaquin after hemorrhagic shock in rats. J Surg Res 2013; 179: 115-124
• 12 ICH-2011. Impurities: Guideline for residual solvents Q3C(R5). http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q3C/Step4/Q3C_R5_Step4.pdf Access Date: September 25, 2013
• 13 Gulati A, Rebello S, Kumar A. Role of sympathetic nervous system in cardiovascular effects of centrally administered endothelin-1 in rats. Am J Physiol 1997; 273: H1177-H1186
• 14 Gulati A, Srimal RC. Endothelin antagonizes the hypotension and potentiates the hypertension induced by clonidine. Eur J Pharmacol 1993; 230: 293-300
• 15 Maggi CA, Meli A. Suitability of urethane anesthesia for physiopharmacological investigations in various systems. Part 2: Cardiovascular system. Experientia 1986; 42: 292-297
• 16 Lavhale MS, Briyal S, Parikh N et al. Endothelin modulates the cardiovascular effects of clonidine in the rat. Pharmacol Res 2010; 62: 489-499
• 17 Pacher P, Nagayama T, Mukhopadhyay P et al. Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats. Nat Protocols 2008; 3: 1422-1434
• 18 Gulati A, Zhang Z, Murphy A et al. Efficacy of centhaquin as a small volume resuscitative agent in severely hemorrhaged rats. Am J Emerg Med 2013; 31: 1315-1321
• 19 Turner PV, Pekow C, Vasbinder MA et al. Administration of substances to laboratory animals: equipment considerations, vehicle selection, and solute preparation. J Am Assoc Lab Anim Sci 2011; 50: 614-627
• 20 Dai W-G. In vitro methods to assess drug precipitation. Int J Pharm 2010; 393: 1-16
• 21 Santos NC, Figueira-C J, Martins-S J et al. Multidisciplinary utilization of dimethyl sulfoxide: pharmacological, cellular, and molecular aspects. Biochem Pharmacol 2003; 65: 1035-1041
• 22 Lacivita E, Leopoldo M, Giorgio PD et al. Determination of 1-aryl-4-propylpiperazine pKa values: The substituent on aryl modulates basicity. Bioorg Med Chem 2009; 17: 1339-1344